Articles

Strategic Partnerships for Unlocking Product Potential

A New Paradigm in Research and Clinical Data Collection

ERP Implementation Case Studies

With the increasing volumes of adverse event reports and stagnant budgets, the time is now for a revolutionary change in drug and device safety case management. A robust management process is necessary for identifying and evaluating adverse events (AE) and reporting them properly to regulators.

The Next Domino: Automation, AI, and touchless safety case processing

What if you could predict potential safety issues before clinical development begins? Innovative new signal detection and management approaches have been developed to help clinical trial sponsors, manufacturers, and CROs combat safety-related challenges and provide insight to be used to predict potential safety issues even before clinical development begins. Applying those learnings to their choice of initial research candidates can ultimately mean safer medicines for patients.

Smarter Signal Management: AI, big data, and predictive analytics

This white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.

The Future of Medicine is Smart

The Impact of False Starts on Omnichannel Efforts 

What Life Sciences Companies Need to Know From Startup to Commercialization

This white paper investigates best practices and tangible benefits associated with a risk-based quality management (RBQM) approach to clinical trial management.

Analysis of Risk-Based Quality Management Approach - White Paper

Life sciences transformations rarely fail because of what was in the plan. They fail because of what was not. Explore five trends that will determine their success in coming years.


Flip the Script

Gain actionable insights from Lash Group experts, leveraging 30+ years of experience launching new programs to help you ensure patient support success. 

Patient Support Launch Guide: Novel Therapies

Analysis of Risk-Based Quality Management Approach

Acoustic Ejection Mass Spectrometry:  The Era of High-Throughput Mass Spectrometry 

Industry experts cover how to develop digital patient solutions that address real unmet needs and secure adoption.


Digital patient solutions: the secret to delivering and securing adoption

In this case study, learn how to increase payer engagement, drive awareness, monitor competition, and leverage insights to enhance strategic plans and  launch success.

Gaining Payer Attention Through Digital Innovation

With bigger patient access and affordability barriers given the new normal of COVID-19, see why field services are more important than ever. Read now.

Solving access, reimbursement, and PAP awareness problems

This whitepaper discusses the importance of patient support programs and why a robust risk mitigation plan is critical to ensure that patients receive their therapy during crises.

Patient Support Programs: Considerations for Crisis Management and Risk Mitigation

In today’s fast-paced marketplace and complicated regulatory environment, operating in the life sciences industry can bring a variety of challenges. From raising capital or addressing pricing pressures to prioritizing development efforts or managing third-party risks, the landscape of Biopharma Finance is changing.

The Changing Landscape of Biopharma Finance 

With the future of face-to-face field sales uncertain, how can pharma ensure product messaging reaches the right healthcare audiences and, ultimately, patients?

All Whitepapers